Verdict94/ 100
Grade A · #1CoreAge Rx
The most honest middle of the market: nationwide access, both molecules at one flat, no-surprise price.
Visit CoreAge RxHead-to-head verdict
CoreAge Rx vs HealthRX
Two GLP-1 providers, compared side by side on The Verdict Score — our published six-factor rubric. Same yardstick, and no score is adjusted for payment.
Published by The GLP-1 Verdict
Pricing sources checked: CoreAge Rx: August 2026 · HealthRX: October 2026
vs
Verdict86/ 100
Grade B · #8HealthRX
Both compounded injections with the full plan table published on-site — though the headline $99 and $179 rates are 12-month prepay floors, not what a month-to-month patient pays.
Visit HealthRXThe verdict
Winner: CoreAge Rx
CoreAge Rx takes it with a higher Verdict Score — 94/100 to 86/100 (grade A vs B). Anyone who wants transparent flat pricing and nationwide access without a teaser-rate bait-and-switch. HealthRX still earns its place — patients who want posted prices before they start and are willing to prepay a year to reach the lowest published rate.
The score compares published program terms and features; it does not measure clinical outcomes or predict which treatment will suit you.
Factor by factor
Both scored on the same six factors — see the methodology. The brass bar marks the stronger side on each.
92Real-world results85
92
Real-world results85
97Price honesty85
97
Price honesty85
96Prescriber access89
96
Prescriber access89
88Formulary choice90
88
Formulary choice90
95Cancellation fairness84
95
Cancellation fairness84
93Member support84
93
Member support84
Price, coverage & features
| Metric | CoreAge Rx | HealthRX |
|---|---|---|
| Verdict Score | 94/100 | 86/100 |
| Grade | A | B |
| Semaglutide | $99/mo | $99/mo (annual) |
| Tirzepatide | $149/mo | $179/mo (annual) |
| Coverage | All 50 states | All 50 states |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | No | No |
CoreAge Rx
What we like
- Flat, all-in monthly price with no intro-rate step-ups after month one
- Both compounded semaglutide and tirzepatide on one account
- Available in all 50 states
- Straightforward, low-friction cancellation
The caveats
- Not the cheapest — flat-price challengers like Trimi Health and Alan Meds undercut its sticker price
- No FDA-approved brand-name option (compounded only)
- Does not yet publicly name its 503A/B pharmacy partner
HealthRX
What we like
- Physician-supervised intake with licensed prescribers
- Carries both molecules, shipped overnight from a 503A compounding pharmacy with no signature needed
- Full plan table published on-site with a current-as-of date: semaglutide $190/mo month-to-month down to $99/mo on the 12-month plan, tirzepatide $239/mo down to $179/mo — no insurance required
- Unshipped doses refunded when you cancel, and a full refund if a provider doesn't approve you
The caveats
- GLP-1 is compounded, not FDA-approved — the standard verification caveat applies
- The advertised $99 and $179 rates require a 12-month prepay — $1,188 and $2,148 up front; month-to-month runs $190 and $239
- Compounded injections only — no brand-name pen and no oral tablet
- You pay at checkout before the medical intake, and cancellation is by email to the support team
Our pick — visit
Anyone who wants transparent flat pricing and nationwide access without a teaser-rate bait-and-switch.
Visit CoreAge Rx Read the full CoreAge Rx review →Also worth a look
Patients who want posted prices before they start and are willing to prepay a year to reach the lowest published rate.
Visit HealthRX Read the full HealthRX review →Keep comparing
Neither of these has to be the answer: the rivals we rank against CoreAge Rx cover the 7 programs closest to it, and the same shortlist for HealthRX does the reverse.
More on CoreAge Rx
Or browse the full comparison hub, every head-to-head A to Z and the complete rankings.
Pricing, states and verification reflect each provider's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.